M3dicine Investors

M3dicine is a medical device platform company that focuses on designing the next generation of medical devices. Their flagship product, Stethee Pro, is the worlds first wireless electronic stethoscope with machine learning algorithms for cardiac and respiratory events detection. It captures heart sounds and measures systole and diastole durations, as well as captures lung sounds and monitors respiratory rate. With Stethee Pro, healthcare professionals can gain an unprecedented level of understanding of their patients heart function in just 20 seconds. M3dicine has revolutionized the field of auscultation and provided clinicians with a powerful tool for triage, screening, and clinical evaluation.

Headquarters: Eight Mile Plains, Queensland, Australia
Founded Date: 2015.0
Industry: Biohacking
Employee Number: 47.0